Chowdhury Sayantani, Ghosh Sumit, Das Abhishek Kumar, Sil Parames C
Division of Molecular Medicine, Bose Institute, Kolkata, India.
Front Pharmacol. 2019 Feb 5;10:27. doi: 10.3389/fphar.2019.00027. eCollection 2019.
Oxidative insult, inflammation, apoptosis and autophagy play a pivotal role in the etiology of diabetic nephropathy, a global health concern. Ferulic acid, a phytochemical, is reported to protect against varied diseased conditions. However, the ameliorative role and mechanisms of ferulic acid in averting STZ-mediated nephrotoxicity largely remains unknown. For study, a single intraperitoneal injection of streptozotocin (50 mg kg body wt.) was administered in experimental rats to induce diabetes. The diabetic rats exhibited a rise in blood glucose level as well as kidney to body weight ratio, a decrease in serum insulin level, severe kidney tissue damage and dysfunction. Elevation of intracellular ROS level, altered mitochondrial membrane potential and cellular redox balance impairment shown the participation of oxidative stress in hyperglycemia-triggered renal injury. Treatment with ferulic acid (50 mg kg body wt., orally for 8 weeks), post-diabetic induction, could markedly ameliorate kidney injury, renal cell apoptosis, inflammation and defective autophagy in the kidneys. The underlying mechanism for such protection involved the modulation of AGEs, MAPKs (p38, JNK, and ERK 1/2), NF-κB mediated inflammatory pathways, mitochondria-dependent and -independent apoptosis as well as autophagy induction. In cultured NRK-52E cells, ferulic acid (at an optimum dose of 75 μM) could counter excessive ROS generation, induce autophagy and inhibit apoptotic death of cells under high glucose environment. Blockade of autophagy could significantly eradicate the protective effect of ferulic acid in high glucose-mediated cell death. Together, the study confirmed that ferulic acid, exhibiting hypoglycemic, antioxidant, anti-inflammatory, anti-apoptotic activities and role in autophagy, could circumvent oxidative stress-mediated renal cell damage.
氧化损伤、炎症、细胞凋亡和自噬在糖尿病肾病的病因中起着关键作用,这是一个全球性的健康问题。阿魏酸是一种植物化学物质,据报道可预防多种疾病。然而,阿魏酸在避免链脲佐菌素介导的肾毒性方面的改善作用和机制在很大程度上仍不清楚。在本研究中,对实验大鼠进行单次腹腔注射链脲佐菌素(50 mg/kg体重)以诱导糖尿病。糖尿病大鼠的血糖水平以及肾重与体重比升高,血清胰岛素水平降低,肾脏组织严重损伤且功能障碍。细胞内活性氧水平升高、线粒体膜电位改变和细胞氧化还原平衡受损表明氧化应激参与了高血糖引发的肾损伤。糖尿病诱导后,用阿魏酸(50 mg/kg体重,口服8周)治疗可显著改善肾脏损伤、肾细胞凋亡、炎症和肾脏中自噬缺陷。这种保护作用的潜在机制涉及晚期糖基化终末产物、丝裂原活化蛋白激酶(p38、JNK和ERK 1/2)、核因子κB介导的炎症途径、线粒体依赖性和非依赖性细胞凋亡以及自噬诱导的调节。在培养的NRK-52E细胞中,阿魏酸(最佳剂量为75 μM)可对抗高糖环境下过量的活性氧生成,诱导自噬并抑制细胞凋亡死亡。阻断自噬可显著消除阿魏酸对高糖介导的细胞死亡的保护作用。总之,该研究证实阿魏酸具有降血糖、抗氧化、抗炎、抗凋亡活性以及在自噬中的作用,可规避氧化应激介导的肾细胞损伤。